Singapore - English - HSA (Health Sciences Authority)

orient europharma pte ltd - rotigotine - patch - 4.5 mg/10 cm2

Singapore - English - HSA (Health Sciences Authority)

orient europharma pte ltd - rotigotine - patch - 9.0 mg/20 cm2

Singapore - English - HSA (Health Sciences Authority)

orient europharma pte ltd - rotigotine - patch - 13.5 mg/30 cm2

Singapore - English - HSA (Health Sciences Authority)

orient europharma pte ltd - rotigotine - patch - 18 mg/40 cm2

European Union - English - EMA (European Medicines Agency)

ucb pharma s.a.   - rotigotine - restless legs syndrome; parkinson disease - anti-parkinson drugs - leganto is indicated for the symptomatic treatment of moderate to severe idiopathic restless-legs syndrome in adults.leganto is indicated for the treatment of the signs and symptoms of early-stage idiopathic parkinson’s disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or ‘on-off’ fluctuations).

European Union - English - EMA (European Medicines Agency)

ucb pharma s.a. - rotigotine - restless legs syndrome; parkinson disease - anti-parkinson drugs - parkinson's disease: neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or 'on-off' fluctuations).restless-legs syndrome: neupro is indicated for the symptomatic treatment of moderate to severe idiopathic restless-legs syndrome in adults.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - rotigotine - transdermal patch - 2mg/24hour

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - rotigotine - transdermal patch - 4mg/24hour

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - rotigotine - transdermal patch - 6mg/24hour

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - rotigotine - transdermal patch - 8mg/24hour